For a better user experience please update your browser or use Chrome or Firefox browser.
Utilities
Publication detail
HomeGuidance for the safe management of hazardous medicinal products at work
There is a newer edition of this publication
Publication metadata
For the purposes of this guide, hazardous medicinal products (HMPs) are defined as medicinal products that contain one or more substances that meet the criteria for classification as: Carcinogenic (category 1A or 1B), Mutagenic (category 1A or 1B) or Toxic for reproduction (category 1A or 1B) in accordance with Regulation (EC) No 1272/2008 (the CLP Regulation). This includes medicinal products for both human and veterinary use. By virtue of the working definition given above, HMPs fall within the scope of Directive 2004/37/EC (the Carcinogens, Mutagens and Reprotoxic Substances Directive, CMRD). HMPs include some antineoplastics, immunosuppressants, antiviral medicines, and other. HMPs are used to treat a wide range of medical conditions including cancer treatment and rheumatology. HMPs can cause unintended effects in people other than the patients themselves, such as the workers who are exposed to them.
- Published:
- Corporate author(s): Directorate-General for Employment, Social Affairs and Inclusion (European Commission)
- Themes: Public health
- Subject: dangerous substance , health risk , medicinal product , occupational safety , user guide , veterinary medicinal product
ISBN
978-92-76-59099-6
DOI
10.2767/052571
Catalogue number
KE-03-22-175-EN-N
ISBN
978-92-68-02978-7
DOI
10.2767/153531
Catalogue number
KE-03-22-175-EN-C
|
PDF
|
|||
| ISSN | ISBN 978-92-76-59099-6 | DOI 10.2767/052571 | Catalogue number KE-03-22-175-EN-N |
|
Paper
|
|||
| ISSN | ISBN 978-92-68-02978-7 | DOI 10.2767/153531 | Catalogue number KE-03-22-175-EN-C |
- Released on EU publications website:
Document viewer
Note:
The publication cannot be displayed in the document viewer. Open web version
You may access it from: Download and languages